Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11753443 Conjugated hepcidin mimetics

Patent 11753443 was granted and assigned to Protagonist Therapeutics on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Protagonist Therapeutics

Current Assignee

Protagonist Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Jie Zhang

Adam Stephenson

Brian Troy Frederick

David Liu

Ashok Bhandari

Gregory Thomas Bourne

Mark Leslie Smythe

Roopa Taranath

Date of Patent

September 12, 2023

Patent Application Number

16964708

Date Filed

February 8, 2019

Patent Citations

US Patent 8435941 Mini-hepcidin peptides and methods of using thereof

US Patent 7534764 Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin

US Patent 7589170 Synthesis of cyclic peptides

US Patent 7718598 Auxiliary for amide bond formation

US Patent 7745391 Human thrombospondin polypeptide

US Patent 8313950 Hepcidins as biomarkers for impending lupus nephritis flare

US Patent 10196424 Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

US Patent 10278957 Opioid agonist peptides and uses thereof

...

Patent Primary Examiner

CPC Code

The present invention provides hepcidin analogues with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11753443 Conjugated hepcidin mimetics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.